PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
January 9, 2005European Heart Journal1,656 citationsOpen Access

Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS)

View Full Paper
MFMarcus FlatherMSMarcelo C. ShibataACAndrew J.S. Coats

Structured PICO

Does nebivolol reduce mortality and cardiovascular hospital admission in elderly patients with heart failure?

P
Population
Elderly patients with heart failure
I
Intervention
Nebivolol
O
Outcome
Mortality and cardiovascular hospital admissioncomposite

Nebivolol is an effective and well-tolerated treatment for heart failure in elderly patients.

Abstract

Nebivolol, a beta-blocker with vasodilating properties, is an effective and well-tolerated treatment for heart failure in the elderly.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Flather et al. (2005) studied this question.

synapsesocial.com/papers/6996136983d686757580cd7bhttps://doi.org/10.1093/eurheartj/ehi115
Ask AI
Helpful
Bookmark
Share
View Full Paper